Inventor · disambiguated record
Kevin Greenman
Also filed as: GREENMAN KEVIN · GREENMAN KEVIN LLOYD
20 granted patents·16 pending applications·217 citations·filing 2006–2025
95Inventor score
Files withCHEMOCENTRYX INC19MAYO FOUND MEDICAL EDUCATION & RES9AMGEN INC2FAN PINGCHEN2FEDICHEV PETR OLEGOVICH1
Top patents by PatentIndex Score
36 records- 0197US10035768B2C5aR antagonistsCHEMOCENTRYX INC·Filed 2017·Granted Jul 31, 2018·23 cites·10 claims
- 0297US9573897B2C5AR antagonistsCHEMOCENTRYX INC·Filed 2015·Granted Feb 21, 2017·24 cites·9 claims
- 0396US8906938B2C5aR antagonistsCHEMOCENTRYX INC·Filed 2013·Granted Dec 9, 2014·28 cites·5 claims
- 0495US10660897B2C5aR antagonistsCHEMOCENTRYX INC·Filed 2018·Granted May 26, 2020·6 cites·5 claims
- 0595US9126939B2C5AR antagonistsFAN PINGCHEN·Filed 2011·Granted Sep 8, 2015·30 cites·4 claims
- 0695US8445515B2C5aR antagonistsFAN PINGCHEN·Filed 2009·Granted May 21, 2013·38 cites·25 claims
- 0794US7790726B2Monocyclic and bicyclic compounds and methods of useCHEMOCENTRYX INC·Filed 2006·Granted Sep 7, 2010·34 cites·7 claims
- 0892US10160769B2Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereofUNIV MICHIGAN REGENTS·Filed 2016·Granted Dec 25, 2018·10 cites·25 claims
- 0990US11339126B2Compounds for the reducing lipotoxic damageMAYO FOUND MEDICAL EDUCATION & RES·Filed 2018·Granted May 24, 2022·3 cites·15 claims
- 1089US7777035B2Azaindazole compounds and methods of useCHEMOCENTRYX INC·Filed 2007·Granted Aug 17, 2010·9 cites·10 claims
- 1187US10774045B2Compounds for modulating mitochondrial functionMAYO FOUND MEDICAL EDUCATION & RES·Filed 2019·Granted Sep 15, 2020·2 cites·18 claims
- 1285US12325690B2Compounds for the reducing lipotoxic damageMAYO FOUND MEDICAL EDUCATION & RES·Filed 2024·Granted Jun 10, 2025·0 cites·11 claims
- 1385US7576106B2Piperidine derivatives and methods of useCHEMOCENTRYX INC·Filed 2006·Granted Aug 18, 2009·4 cites·17 claims
- 1484US11161814B2Compounds for modulating mitochondrial functionMAYO FOUND MEDICAL EDUCATION & RES·Filed 2020·Granted Nov 2, 2021·1 cites·17 claims
- 1583US2023102258A1C5ar antagonistsCHEMOCENTRYX INC·Filed 2022·Application pending·0 cites
- 1682US11976040B2Compounds for the reducing lipotoxic damageMAYO FOUND MEDICAL EDUCATION & RES·Filed 2023·Granted May 7, 2024·0 cites·21 claims
- 1782US7576218B24-phenylpiperdine-pyrazole CCR1 antagonistsCHEMOCENTRYX INC·Filed 2006·Granted Aug 18, 2009·3 cites·9 claims
- 1880US2025340512A1Compounds for the reducing lipotoxic damageMAYO FOUND MEDICAL EDUCATION & RES·Filed 2025·Application pending·0 cites
- 1979US10336700B2Compounds for modulating mitochondrial functionMAYO FOUND MEDICAL EDUCATION & RES·Filed 2016·Granted Jul 2, 2019·2 cites·16 claims
- 2078US11623915B2Compounds for the reducing lipotoxic damageMAYO FOUND MEDICAL EDUCATION & RES·Filed 2022·Granted Apr 11, 2023·0 cites·11 claims
- 2174US12017992B2Compounds for modulating mitochondrial functionMAYO FOUND MEDICAL EDUCATION & RES·Filed 2021·Granted Jun 25, 2024·0 cites·17 claims
- 2274US2021269398A1C5ar antagonistsCHEMOCENTRYX INC·Filed 2020·Application pending·0 cites
- 2367US2019062275A1C5aR ANTAGONISTSCHEMOCENTRYX INC·Filed 2018·Application pending·0 cites
- 2466US2015141425A1C5aR ANTAGONISTSCHEMOCENTRYX INC·Filed 2014·Application pending·0 cites
- 2565US2024409557A15,6-fused and 6,6-fused bicyclic alcohols and ethers and compositions for use as 15-prostaglandin dehydrogenase modulatorsAMGEN INC·Filed 2024·Application pending·0 cites
- 2662US2017114017A1C5ar antagonistsCHEMOCENTRYX INC·Filed 2017·Application pending·0 cites
- 2762US2025282785A1Pyrrolidinone derivatives as inhibitors of nf kappa b inducing kinaseJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 2861US9296740B2Azaindazole compounds and methods of useCHEMOCENTRYX INC·Filed 2013·Granted Mar 29, 2016·0 cites·19 claims
- 2961US2018250293A1Azaindazole compounds and methods of useCHEMOCENTRYX INC·Filed 2017·Application pending·0 cites
- 3061US2017065604A1C5aR ANTAGONISTSCHEMOCENTRYX INC·Filed 2016·Application pending·0 cites
- 3156US2010311753A1C5aR ANTAGONISTSCHEMOCENTRYX INC·Filed 2010·Application pending·0 cites
- 3256US2016296517A1Azaindazole compounds and methods of useCHEMOCENTRYX INC·Filed 2016·Application pending·0 cites
- 3355US2023047816A1Pfkfb3 inhibitors and their usesFEDICHEV PETR OLEGOVICH·Filed 2021·Application pending·0 cites
- 3455US2023339886A1Rev-erb agonists for the treatment of th17-mediated inflammatory disordersUNIV FLORIDA·Filed 2021·Application pending·0 cites
- 3554US2024124442A1Tricyclic-amido-bicyclic prmt5 inhibitorsAMGEN INC·Filed 2022·Application pending·0 cites
- 3639US2011275639A1C5aR ANTAGONISTSCHEMOCENTRYX INC·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kevin Greenman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →